Takeda Pharmaceutical Co Ltd ADR (TAK) — Free Cash Flow Generation Index
Takeda Pharmaceutical Co Ltd ADR (TAK) has a Free Cash Flow Generation Index of 0.88x as of December 2025. Free cash flow of $317.47 Billion represents 1% of operating cash flow ($360.04 Billion). Explore TAK capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Takeda Pharmaceutical Co Ltd ADR Free Cash Flow Generation Index (2000–2025)
Historical FCF Generation Index trend for Takeda Pharmaceutical Co Ltd ADR across 26 annual periods. For the full cash flow conversion analysis, see how efficiently does Takeda Pharmaceutical Co Ltd ADR generate cash.
Annual Free Cash Flow Generation for Takeda Pharmaceutical Co Ltd ADR (2000–2025)
Year-by-year Free Cash Flow Generation Index for Takeda Pharmaceutical Co Ltd ADR. Check TAK cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.81x | $856.39 Billion | $1.06 Trillion | $200.79 Billion | ▲ +146.3% |
| 2024 | 0.33x | $235.61 Billion | $716.34 Billion | $480.73 Billion | ▼ -6.4% |
| 2023 | 0.35x | $343.47 Billion | $977.16 Billion | $633.69 Billion | ▼ -57.9% |
| 2022 | 0.83x | $937.07 Billion | $1.12 Trillion | $186.04 Billion | ▲ +8.9% |
| 2021 | 0.77x | $774.46 Billion | $1.01 Trillion | $236.47 Billion | ▲ +13.5% |
| 2020 | 0.67x | $452.04 Billion | $669.75 Billion | $217.71 Billion | ▲ +14.1% |
| 2019 | 0.59x | $194.37 Billion | $328.48 Billion | $134.11 Billion | ▼ -10.4% |
| 2018 | 0.66x | $249.59 Billion | $377.85 Billion | $128.26 Billion | ▲ +15.6% |
| 2017 | 0.57x | $149.34 Billion | $261.36 Billion | $112.03 Billion | ▲ +124.5% |
| 2016 | -2.33x | $-59.37 Billion | $25.49 Billion | $84.86 Billion | ▼ -676.0% |
| 2015 | 0.40x | $73.80 Billion | $182.52 Billion | $108.72 Billion | ▼ -14.1% |
| 2014 | 0.47x | $69.82 Billion | $148.34 Billion | $78.52 Billion | ▼ -31.7% |
| 2013 | 0.69x | $211.95 Billion | $307.71 Billion | $95.76 Billion | ▼ -15.6% |
| 2012 | 0.82x | $274.67 Billion | $336.57 Billion | $61.90 Billion | ▲ +31.6% |
| 2011 | 0.62x | $202.77 Billion | $326.94 Billion | $124.17 Billion | ▼ -19.6% |
| 2010 | 0.77x | $294.21 Billion | $381.17 Billion | $86.96 Billion | ▼ -12.2% |
| 2009 | 0.88x | $286.81 Billion | $326.27 Billion | $39.46 Billion | ▼ -1.1% |
| 2008 | 0.89x | $259.88 Billion | $292.50 Billion | $32.62 Billion | ▲ +3.2% |
| 2007 | 0.86x | $180.13 Billion | $209.28 Billion | $29.15 Billion | ▼ -5.8% |
| 2006 | 0.91x | $341.48 Billion | $373.57 Billion | $32.09 Billion | ▲ +11.7% |
| 2005 | 0.82x | $241.87 Billion | $295.54 Billion | $53.67 Billion | ▼ -0.9% |
| 2004 | 0.83x | $256.96 Billion | $311.12 Billion | $54.16 Billion | ▼ -5.4% |
| 2003 | 0.87x | $229.97 Billion | $263.45 Billion | $33.48 Billion | ▲ +3.4% |
| 2002 | 0.84x | $203.06 Billion | $240.59 Billion | $37.52 Billion | ▼ -3.4% |
| 2001 | 0.87x | $185.72 Billion | $212.66 Billion | $26.94 Billion | ▲ +12.4% |
| 2000 | 0.78x | $123.54 Billion | $158.96 Billion | $35.42 Billion | — |